Genetic and epigenetic regulation of cortactin (CTTN) by inflammatory factors and mechanical stress in human lung endothelial cells.

Autor: Sun X; Department of Medicine, University of Arizona, Tucson, AZ, U.S.A., Sun B; Department of Pathology, University of Arizona, Tucson, AZ, U.S.A., Sammani S; Department of Medicine, University of Arizona, Tucson, AZ, U.S.A., Dudek SM; Department of Medicine, University of Illinois Chicago, Chicago IL, U.S.A., Belvitch P; Department of Medicine, University of Illinois Chicago, Chicago IL, U.S.A., Camp SM; University of Florida, UF Scripps Research Institute, Jupiter, FL, U.S.A., Zhang D; College of Pharmacy, University of Arizona, Tucson, AZ, U.S.A., Bime C; Department of Medicine, University of Arizona, Tucson, AZ, U.S.A., Garcia JGN; Department of Medicine, University of Arizona, Tucson, AZ, U.S.A.; University of Florida, UF Scripps Research Institute, Jupiter, FL, U.S.A.
Jazyk: angličtina
Zdroj: Bioscience reports [Biosci Rep] 2024 Sep 25; Vol. 44 (9).
DOI: 10.1042/BSR20231934
Abstrakt: Rationale: Cortactin, an actin-binding cytoskeletal protein, plays a crucial role in maintaining endothelial cell (EC) barrier integrity and regulating vascular permeability. The gene encoding cortactin, CTTN, is implicated in various lung inflammatory disorders. Despite this, the transcriptional regulation of CTTN by inflammatory stimuli and promoter SNPs remains unexplored.
Methods: We transfected human lung ECs with a full-length CTTN promoters linked to a luciferase reporter to measure promoter activity. SNP-containing CTTN promoter was created via site-directed mutagenesis. Transfected ECs were exposed to LPS (PAMP), TNF-α (cytokine), cyclic stretch (CS), FG-4592 (HIF-inducer), NRF2 (anti-oxidant modulator), FTY-(S)-phosphate (endothelial barrier enhancer), and 5'-Aza (demethylation inducer). Immunohistochemistry was used to assess cortactin expression in mouse lungs exposed to LPS.
Results: LPS, TNF-α, and 18%CS significantly increased CTTN promoter activities in a time-dependent manner (P<0.05). The variant rs34612166 (-212T/C) markedly enhanced LPS- and 18%CS- induced CTTN promoter activities (P<0.05). FG-4592 significantly boosted CTTN promoter activities (P<0.01), which were partially inhibited by HIF1α (KC7F2) and HIF2α (PT2385) inhibitors (P<0.05). NRF2 activator Bixin increased CTTN promoter activities, whereas NRF2 inhibitor Brusatol reduced them (P<0.05). 5'-Aza increased CTTN promoter activities by 2.9-fold (P<0.05). NF-κB response element mutations significantly reduced CTTN promoter activities response to LPS and TNFα. FTY-(S)-phosphate significantly increased CTTN promoter activities in 24 h. In vivo, cortactin levels were significantly elevated in inflammatory mouse lungs exposed to LPS for 18 h.
Conclusion: CTTN transcriptional is significantly influenced by inflammatory factors and promoter variants. Cortactin, essential in mitigating inflammatory edema, presents a promising therapeutic target to alleviate severe inflammatory disorders.
(© 2024 The Author(s).)
Databáze: MEDLINE